Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker based study (Alliance A032102).
Year: 2025
Type: conference-abstract
Study design: Study Protocol
Source: Journal of Clinical Oncology
Institutions: University of California San Diego, Moores Cancer Center, Memorial Sloan Kettering Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, University of Kansas Medical Center, Medical Oncology Hematology Consultants, Vanderbilt University Medical Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Dana-Farber Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410809591